中關村(000931.SZ):預計2019年淨利0.9億至1億元 同比變動-3.37%至7.37%
格隆匯1月20日丨中關村(000931.SZ)披露2019年度業績預告,公司預計2019年1-12月實現歸屬於上市公司股東的淨利潤約0.9億元至1億元,同比變動-3.37%至7.37%。
公司各項業務2019年正常開展,業績同比變動主要原因如下:
1、2019年度公司繼續深耕醫藥大健康業務,醫藥業務報告期銷售勢頭良好,報告期營業收入及歸屬於上市公司股東的扣除非經常性損益的淨利潤同比均實現增長。報告期內,主要藥品博蘇(富馬酸比索洛爾片)銷售收入超過3.5億元,再創歷史新高;元治(鹽酸貝尼地平片)繼續實現高速增長,銷售收入突破2億元;下屬醫藥公司多多藥業有限公司生產經營穩健,淨利潤同比增長約20%。
2、2019年歸屬於上市公司股東的淨利潤預計0.9億元至1億元之間,其中非經常性損益金額約3000萬元(所得税影響額後),主要是福州華電房地產公司擔保追償權糾紛系列案的陸續解決,對公司報告期業績產生積極影響。扣除非經常性損益後歸屬於上市公司股東的淨利潤較上年同期大幅增長。
3、其餘各板塊公司業務正常開展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.